Laboratory Corporation of America Holdings

LH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LH stands at 21.8B. In comparison, NVST has a market cap of 3.1B. Regarding current trading prices, LH is priced at $261.10, while NVST trades at $18.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LH currently has a P/E ratio of 30.15, whereas NVST's P/E ratio is -2.82. In terms of profitability, LH's ROE is +0.09%, compared to NVST's ROE of -0.37%. Regarding short-term risk, LH is less volatile compared to NVST. This indicates potentially lower risk in terms of short-term price fluctuations for LH.

LH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LH stands at 21.8B. In comparison, CON has a market cap of 2.7B. Regarding current trading prices, LH is priced at $261.10, while CON trades at $21.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LH currently has a P/E ratio of 30.15, whereas CON's P/E ratio is 15.66. In terms of profitability, LH's ROE is +0.09%, compared to CON's ROE of +0.34%. Regarding short-term risk, LH is more volatile compared to CON. This indicates potentially higher risk in terms of short-term price fluctuations for LH.

LH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LH stands at 21.8B. In comparison, BBNX has a market cap of 828.5M. Regarding current trading prices, LH is priced at $261.10, while BBNX trades at $19.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LH currently has a P/E ratio of 30.15, whereas BBNX's P/E ratio is -11.65. In terms of profitability, LH's ROE is +0.09%, compared to BBNX's ROE of -0.57%. Regarding short-term risk, LH is less volatile compared to BBNX. This indicates potentially lower risk in terms of short-term price fluctuations for LH.

LH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LH stands at 21.8B. In comparison, KDLY has a market cap of 83.5M. Regarding current trading prices, LH is priced at $261.10, while KDLY trades at $13.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LH currently has a P/E ratio of 30.15, whereas KDLY's P/E ratio is -19.00. In terms of profitability, LH's ROE is +0.09%, compared to KDLY's ROE of -1.46%. Regarding short-term risk, LH is less volatile compared to KDLY. This indicates potentially lower risk in terms of short-term price fluctuations for LH.

LH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LH stands at 21.8B. In comparison, NEUE has a market cap of 61.2M. Regarding current trading prices, LH is priced at $261.10, while NEUE trades at $6.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LH currently has a P/E ratio of 30.15, whereas NEUE's P/E ratio is -0.31. In terms of profitability, LH's ROE is +0.09%, compared to NEUE's ROE of +0.22%. Regarding short-term risk, LH is more volatile compared to NEUE. This indicates potentially higher risk in terms of short-term price fluctuations for LH.